Veru Inc. VERU
Set alert
2.19 USD -0.04 -1.79%
At close · Oct 30
2.19 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
2.16 Day range 2.26
2.09 52-week range 4.23
- YTD
- +2.34%
- 1 year
- -27.24%
- Open
- 2.25
- Prev close
- 2.23
- Mkt cap
- 37.34M
- Vol
- 78.95K
- Avg vol
- 221.21K
- EPS
- -0.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.16
- High
- 2.26
- Forward P/E
- -2.23
- Beta
- -0.46
- Short ratio
- 13.35
- Inst. own
- 42.04%
- Dividend
- 0.00
- Ex-div date
- Apr 27, 2014
- 50-d avg
- 0.7422
- 200-d avg
- 0.90395
- 1y target
- 3.40
2Y chart
Events in this range
- Nov 5, 2024Rating: Oppenheimer · Outperform → Outperform
- Dec 16, 2024Earnings: -0.06; estimate -0.07; surprise 14.29%
- Dec 20, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 11, 2025Split: 1 for 10
Signals (90)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 4 weeks ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 4 months ago |
| RSI: Overbought | Jun 4, 2026 | 4 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 24, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Apr 14, 2026 | 6 months ago |
| SMA: Bearish | Apr 10, 2026 | 6 months ago |
| SMA: Bullish | Apr 7, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 6 months ago |
| RSI: Oversold | Mar 27, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 20, 2026 | 8 months ago |
| SMA: Bearish | Feb 5, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 8 months ago |
| SMA: Bullish | Jan 15, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 2, 2026 | 10 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| RSI: Oversold | Nov 19, 2025 | 11 months ago |
| RSI: Oversold | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 28, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 23, 2025 | 1 year ago |
| SMA: Bullish | Oct 1, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 22, 2025 | 1 year ago |
| RSI: Oversold | Aug 19, 2025 | 1 year ago |
| RSI: Oversold | Aug 6, 2025 | 1 year ago |
| SMA: Bearish | Jul 25, 2025 | 1 year ago |
| SMA: Bullish | Jul 24, 2025 | 1 year ago |
| SMA: Bearish | Jul 22, 2025 | 1 year ago |
| SMA: Bullish | Jul 10, 2025 | 1 year ago |
| SMA: Bearish | Jul 9, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| RSI: Overbought | Jun 4, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 29, 2025 | 1 year ago |
| SMA: Bullish | May 28, 2025 | 1 year ago |
| MACD: Buy Signal | May 28, 2025 | 1 year ago |
| MACD: Sell Signal | May 21, 2025 | 1 year ago |
| MACD: Buy Signal | May 16, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| MACD: Sell Signal | May 1, 2025 | 1 year ago |
| SMA: Bullish | Apr 29, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 29, 2025 | 1 year ago |
| SMA: Bearish | Apr 28, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 24, 2025 | 1 year ago |
| SMA: Bullish | Apr 22, 2025 | 1 year ago |
| SMA: Bearish | Apr 15, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 11, 2025 | 1 year ago |
| SMA: Bearish | Apr 8, 2025 | 1 year ago |
| SMA: Bullish | Apr 1, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 20, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| RSI: Overbought | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
Key statistics
- Market cap
- 94.71M
- Enterprise value
- 99.50M
- Trailing P/E
- 0.00
- Forward P/E
- -2.23
- PEG ratio
- 0.00
- Price / sales
- 6.72
- Price / book
- 2.52
- EPS (TTM)
- -0.28
- Beta
- -0.46
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -265.42%
- Revenue (TTM)
- 14.09M
- Revenue growth
- 18.30%
- Free cash flow
- -33.98M
- Total cash
- 29.15M
- Total debt
- 13.68M
- Return on equity
- -126.72%
- Shares outstanding
- 146.38M
- Short % of float
- 9.70%
- 50-day average
- 0.7422
- 200-day average
- 0.90395
Analyst view
Consensus: buy
Buy
Price target (mean) 3.40 +55.3% upside
Now 2.19
- Target (low)
- 1.00
- Target (mean)
- 3.40
- Target (high)
- 5.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy2
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
VERU Revenue — quarterly 0
VERU Net income — quarterly -6.99M
VERU EPS — quarterly -0.30
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 16, 2024 | Sep 1, 2024 | -0.07 | -0.06 | +0.01 | +14.29% |
| Aug 8, 2024 | Jun 1, 2024 | -0.06 | -0.07 | -0.01 | -16.67% |
| May 8, 2024 | Mar 1, 2024 | -0.05 | -0.07 | -0.02 | -40.00% |
| Dec 8, 2023 | Sep 1, 2023 | -0.20 | -0.16 | +0.04 | +20.00% |
| Aug 10, 2023 | Jun 1, 2023 | -0.20 | -0.13 | +0.07 | +35.00% |
| May 11, 2023 | Mar 1, 2023 | -0.33 | -0.44 | -0.11 | -33.33% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Nov 5, 2024 | Oppenheimer | reit | Outperform | Outperform |
| May 14, 2024 | B. Riley Securities | init | — | Buy |
| May 13, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 6, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Apr 15, 2024 | Oppenheimer | reit | Outperform | Outperform |
About Veru Inc.
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- verupharma.com
News
Your note
Sign in to keep a note on VERU — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARNETTE K GARY PH.D. | Officer | Purchase | May 23, 2024 | 5,000 |
| FISCH HARRY | Officer and Director | Purchase | May 23, 2024 | 8,013,830 |
| STEINER MITCHELL SHUSTER | Chief Executive Officer | Sale | May 23, 2024 | 7,086,710 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 5.63% | 8,235,270 | 5.33M | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 5.37% | 7,861,111 | 5.09M | Sep 29, 2024 |
| Perceptive Advisors Llc | 4.98% | 7,283,157 | 4.71M | Sep 29, 2024 |
| Vanguard Group Inc | 4.24% | 6,200,728 | 4.01M | Sep 29, 2024 |
| Millennium Management Llc | 3.79% | 5,554,807 | 3.59M | Sep 29, 2024 |
| Morgan Stanley | 2.06% | 3,014,633 | 1.95M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.66% | 3,889,604 | 2.52M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.23% | 3,263,421 | 2.11M | Oct 30, 2024 |
| Fidelity Small Cap Index Fund | 0.93% | 1,364,612 | 882.90K | Aug 30, 2024 |
| Vanguard Extended Market Index Fund | 0.86% | 1,258,166 | 814.03K | Sep 29, 2024 |
| iShares Russell 2000 Growth ETF | 0.60% | 876,940 | 567.38K | Oct 30, 2024 |
| Fidelity Extended Market Index Fund | 0.51% | 739,390 | 478.38K | Oct 30, 2024 |